News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Patent News (World)
XTL Biopharma (XTLB)' Lupus Drug hCDR1 Granted Patent For Pharmaceutical Composition & Manufacturing Processes 2/10/2016
BMC Medical Co., Ltd Wins Patent Infringement Litigation Against ResMed (RMD) 2/8/2016
Amarantus BioSciences Receives Dual Notices Of Allowance From European Patent Office For Engineered Skin Substitute (ESS) 2/3/2016
Trianni Announces Issuance Of Patent In Australia 2/3/2016
Cantargia Patent Granted In Australia 2/3/2016
Dipexium Pharmaceuticals (DPRX) Announces Issuance Of Locilex Patents In Australia And New Zealand 2/1/2016
BiondVax Pharmaceuticals's Universal Flu Vaccine Receives Additional US Patent 1/27/2016
Rosetta Genomics Ltd. (ROSG) Granted U.S. Patent Allowance For Use Of Gene Expression Signature For Classification Of Kidney Tumors 1/25/2016
Kadimastem Receives Patent Allowance In The United States For Its Technology In The Field Of Diabetes Treatment 1/21/2016
U.S. Patent & Trademark Office Issues Notice Of Allowance For Can-Fite BioPharma (CFBI)'s Sexual Dysfunction Drug CF602 1/19/2016
Summit Therapeutics Granted Key European Patent For Novel Antibiotic Ridinilazole For Treatment Of C. Difficile Infection 1/19/2016
Orthocell’s ‘Cell Factory’ Granted Patent in U.S. 1/5/2016
VolitionRX Granted Its Third U.S. Patent 1/4/2016
BiondVax Pharmaceuticals Approval For A Patent For Its Universal Flu Vaccine In Israel 12/21/2015
Can-Fite BioPharma (CFBI)'s CF101 Granted Patent In Japan For Intraocular Pressure A Key Cause Of Glaucoma 12/17/2015
OphthaliX Inc. Announces CF101 Is Granted Patent In Japan For Intraocular Pressure A Key Cause Of Glaucoma 12/17/2015
U.S. Patents Issued To Akaal Pharma On S1P1 Receptor Modulators Useful For The Treatment Of Autoimmune And Inflammatory Diseases 12/11/2015
Newly Granted U.S. Composition Of Matter Patent Extends Exclusive Protection For VBL Therapeutics (VBLX)' Lead Drug Candidate VB-111 Until October 2033 12/1/2015
Biocept, Inc. (BIOC) Gains Patent Protection In Hong Kong And Japan 11/30/2015
Enyo Pharma Strengthens Its Arsenal Of Hepatitis B Potential Therapies 11/30/2015
CSIRO Maintains Key Patent For shRNA Gene Silencing Technology After European Opposition 11/18/2015
VolitionRX Granted Its Second U.S. Patent 11/17/2015
Patent Approval For BiondVax Pharmaceuticals: BiondVax Receives Approval For Patent In Korea For Its Universal Flu Vaccine 11/17/2015
Zecotek Photonics Inc. Granted Two U.S. Patents For 3D Display System 11/16/2015
Novogen Limited (NVGN) Patent Covering Cantrixil And Trilexium Accepted In Australia 11/12/2015
Regeneus (RGS.AX) (ASX:RGS) Patent Granted For Allogeneic Stem Cell Technology Platform 11/11/2015
DS Biopharma Obtains A Granted Patent Covering The Use Of DS102 To Treat Fatty Liver Disorders 11/9/2015
BioCad Release: Russian Biotechnological Company Won The Case Against Big Pharma On The Patent Dispute Notable For The Pharmaceutical Industry 11/3/2015
BioPharm Executive: From Bad to Worse: Biotech's Next Political Headache? 10/29/2015
Enzymotec Granted A New U.S. Patent For Vayacog In Pre-Dementia 10/28/2015
Mesoblast (MSB.AX) Release: Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions 10/28/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 10/28/2015
Twi Biotechnology Receives Notice Of Patent Allowance In Korea For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes 10/27/2015
Skystar Bio-Pharmaceutical (CGPN) Receives Approval For T-Factor Animal Supplement Patent From PRC's Patent Office 10/27/2015
Orexo AB (ORXOF) Settles Abstral US Patent Litigation With Actavis (ACT) 10/27/2015
First US Patent Covering Allogeneic Chimeric Antigen Receptor T Cells ("CAR-T") Modified To Reduce Immunogenicity Is Awarded To Celyad 10/23/2015
Horizon Pharma (HZNP) Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID (diclofenac sodium topical solution) 2% 10/22/2015
Intec Pharma Ltd. Expands Intellectual Property With A New Patent For The Accordion Pill In Europe 10/22/2015
LS CancerDiag Receives Patent For Revolutionary Predictive Cancer Diagnostic Method Diagmmr 10/15/2015
Cipher Pharma (DND.TO) Announces Settlement In Patent Litigation For Absorica 10/5/2015
RXi Pharmaceuticals (RXII) Granted Patent In China For Lead Clinical Candidate RXI-109 9/28/2015
Oramed (ORMP) Patent Allowed In The US For Oral Administration Of Proteins 9/24/2015
Rosetta Genomics Ltd. (ROSG) Receives U.S. Patent For Treatment Of Prostate Cancer 9/22/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Canada And China 9/16/2015
Vortex Biosciences Granted Critical Patent For Its Liquid Biopsy Technology 9/15/2015
Atlas Genetics: Grant Of Key US Patent 9/14/2015
LabStyle Innovations Receives Granted Patent In The U.S. Expanding Its IP To Address Management Of Chronic Diseases Through Smart Phones 9/9/2015
Glactone Pharma Is Granted A European Patent 9/9/2015
VolitionRX Granted Its First U.S. Patent 9/9/2015
Allergan (AGN) Announces Agreement With Amneal Related To NAMENDA XR Patent Litigation 9/9/2015
Mylan (MYL) Confirms The U.S. Patent And Trademark Office Institutes Inter Partes Review Proceeding Against Third Copaxone 40 Mg/Ml Dosing Patent On All Claims 9/2/2015
Swecure's Patent For Prevention Of Allergy In Children Receives US Approval 9/1/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice Of Allowance For New Israeli Patent Covering RHB-104 For The Treatment Of Crohn's Disease 8/27/2015
Mylan (MYL) Confirms The U.S. Patent And Trademark Office Institutes Inter Partes Review Proceedings Against Two Copaxone 40 Mg/Ml Dosing Patents 8/26/2015
Caprotec Bioanalytics Awarded US Patent For CCMS Proteome Profiling Technology 8/20/2015
Amarantus BioSciences, Inc. Announces Issuance Of United States Patent Covering Proprietary Compositions Of Matter And Methods Of Use For Product Candidate MANF 8/20/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets 8/20/2015
Enzymotec Granted U.S. Patent For INFAT To Promote Intestinal Development And Maturation 8/19/2015
Pluristem Therapeutics (PSTI) Granted U.S. Patent For Production Methods And Use Of Placental Cell Therapy In A Range Of Indications 8/17/2015
Nuvo Research Inc. (NRI.TO) Announces Grant Of United States Patent For Topical Onychomycosis Formulation 8/11/2015
TWi Pharmaceuticals, Inc. Release: Twi Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In Europe And Russia 8/3/2015
ImmunID Key Technology Patents Covering ImmunTraCkeR And ImmunIG Granted In The United States, Europe, Canada And Japan 7/22/2015
Deutsche Biotech Innovativ AG: Significant Strengthening Of The Patent Protection For The Sepsis Drug Candidate Adrecizumab 7/21/2015
New Zealand Pharmaceuticals Assigns To Altamira Bio 7/20/2015
Zecotek Photonics Inc. Granted Patent From Japanese Patent Office For Its 3D Display Technology 7/8/2015
Summit Therapeutics Granted Key Patent By European Patent Office For Utrophin Modulator SMT C1100 In The Treatment Of DMD 7/7/2015
Auris Medical AG (EARS) Provides Update On U.S. Intellectual Property Portfolio 7/6/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice of Allowance For Two Additional U.S. Patents Covering RHB-104 Ongoing Phase III Crohn's Disease Program 7/1/2015
Amarantus BioSciences, Inc. Announces Issuance Of United States Patent No. 9,066,903 Covering Proprietary Methods Of Administration Of Eltoprazine For The Treatment Of Parkinson's Disease 6/30/2015
Eli Lilly (LLY) Wins Patent Victory in UK Lawsuit 6/25/2015
ISA Pharmaceuticals Further Strengthens IP Position On Lead Compound ISA101 6/23/2015
Vaxon Biotech SA Granted Japanese Patent For New Cancer Vaccine Candidates 6/22/2015
CellResearch Corporation Receives New US Patent Approval For Exclusive Stem Cell Technology Amidst New Partnerships 6/19/2015
U.S. Court of Appeals for the Federal Circuit Finds Teva (TEVA)'s '808 Copaxone Patent Invalid 6/18/2015
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Russia For Oral Administration Of GLP-1 6/16/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Israel, Macau And USA 6/16/2015
Bionomics Limited (BNO.AX) Files Patent For Use Of BNC105 In Combination With PD-1 And CTLA-4 Immuno-Oncology Antibodies 6/15/2015
DS Biopharma Announces Receipt Of Two Notices Of Allowance For U.S. Patent Applications Covering The Manufacture And Methods Of Use For Its Bioactive Compounds 6/15/2015
Provia Laboratories Bio-Banking Technology Achieves First Patent Approval 6/15/2015
China Making Its Mark In Global Biopharma Patent Filings 6/11/2015
Can-Fite BioPharma (CFBI) Granted Notice Of Allowance For Patent Covering Manufacturing Process Of CF101 In The U.S. 6/10/2015
Stempeutics Receives Japan Process Patent For Its Novel Stem Cell Drug 'Stempeucel' 6/8/2015
Pluristem Therapeutics (PSTI) Granted Key Cell Patents In Asia, Russia, Mexico, And Israel 6/1/2015
MediGene AG (MDGEF.PK): US Patent Office Prolongs Term Of Medigene's Patent Relating To Dendritic Cell (DC) Vaccines To 2031 5/28/2015
amp biosimilars AG Successfully Out-Licenses First Biosimilar 5/28/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of European Patent For Kerasal Nail 5/28/2015
Pluristem Life Systems Inc. Granted European Patent For Use Of Cells To Help Treat Damaged Bone Marrow 5/6/2015
Amarantus BioSciences, Inc. Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use For MANF 5/5/2015
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug 'Stempeucel' 4/27/2015
GW Pharmaceuticals (GWPH) Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy 4/27/2015
Forward Pharma (FWP) Receives Decision To Grant From EPO For DMF Patent In Europe 4/27/2015
Probiodrug AG Release: Key Patents On Glutaminyl Cyclase (QC) Inhibition For The Treatment Of Alzheimer’s Disease Granted In Japan 4/23/2015
ERYtech Pharma Strengthens Its Intellectual Property Position In The U.S. 4/21/2015
Emotional Brain Obtains Patent Extension For Its Female Sexual Dysfunction Medication 4/17/2015
AEterna Zentaris (AEZS) Files Additional Patent Application To Strengthen IP Protection Of Zoptarelin Doxorubicin 4/16/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice Of Allowance For Additional U.S. Patent For RHB-105 H. Pylori Bacterial Infection Treatment 4/16/2015
Mylan (MYL) Settles Patent Litigation Related To Viagra 4/14/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering TCR-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/8/2015
USPTO Issues Key US Patent To TiGenix For The Use Of Adipose-Derived Stromal Cells In The Treatment Of Fistulas 4/8/2015
Resverlogix Corporation (RVX.TO) Receives Two Patents For RVX-208 In China 4/7/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering Tcr-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/7/2015
Kamada Ltd. (KMDA) Receives Allowance For Key Canadian Patent For Large Scale Production And Use Of Proprietary Alpha-1 Proteinase Inhibitor 4/1/2015
Mesoblast Limited (MSB.AX) Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 3/27/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent Acceptance Notice For The Use Of TB4 To Prevent Tissue Damage Associated With Heart Attack And Stroke Treatments 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Grant Of EU Patent For MOB-015 Related To Topical Treatment Of Onychomycosis (Nail Fungus) 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent For Kerasal Nail 3/25/2015
Enzymotec Reports A Decision Of The U.S. Patent And Trademark Office 3/24/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents For Their NCEs In Canada, Japan And Korea 3/24/2015
ISA Pharmaceuticals Granted European Patent For The Intradermal Administration Of ISA101 3/24/2015
Suven Life Sciences Ltd Secures 2 (Two) Product Patents For Their NCE’s Through New Mechanism Of Action - H3 Inverse Agonist In USA & New Zealand 3/16/2015
Enzymotec Granted New Patents In The United States And Australia Relevant To Phospholipid-Based Products 3/13/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Eurasia And Israel 3/9/2015
European Patent To Strengthen MediGene AG (MDGEF.PK)'s Dendritic Cell (DC) Vaccines Program 3/5/2015
CSIRO Maintains Foundational Patent For RNAi Gene Silencing Technology After European Opposition 3/2/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treating And Repairing Heart Damage 2/25/2015
XstalBio: US Patent Issued For Stabilization Of Therapeutic Proteins 2/25/2015
iBio, Inc. (IBIO) Adds Anthrax Antibodies To Product Pipeline 2/25/2015
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO Covering Cabaletta For The Treatment Of OPMD 2/24/2015
Opsona Therapeutics Ltd. Patent Issued In USA Covering An Antibody Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/23/2015
Opsona Therapeutics Ltd. Patent Issued In US And EU Covering The Opsona-Developed Antibody OPN-305, Which Is Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/20/2015
Orexo AB (ORXOF) Broadens ZUBSOLV Product Range and Announces Newly Listed Granted U.S. Patent 2/17/2015
Rosetta Genomics Ltd. (ROSG) Announces Key Patent Allowances In U.S. And Europe 2/17/2015
Suven Life Sciences Ltd Secures 4 (Four) Product Patents For Their NCE’s Through New Mechanism Of Action – H3 Inverse Agonist In Australia, Canada, Japan And New Zealand 2/16/2015
New Reverdia Patents Strengthen Biosuccinium™ Licensing 2/12/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent Related To MOB-015 For The Treatment Of Onychomycosis 2/11/2015
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015
Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating To NEXAVAR 2/9/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
Enzymotec Announces Favorable Response From The Australian Patent Office 2/3/2015
Provectus Biopharmaceuticals Inc.’ Novel Synthesis Patent Application Allowed By Chinese Patent Office 1/26/2015
Ablynx (ABLYF) Successfully Opposes Patent Appeal Case By Domantis Limited (GlaxoSmithKline (GSK)) 1/22/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Australia & Hong Kong, Two (2) Product Patents From Japan 1/20/2015
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Israel For Oral Administration Of GLP-1 1/16/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents And Multiple Myeloma Therapeutics" With Dr. Xiang-Qun (Sean) Xie, Professor Of Pharmaceutical Sciences At University of Pittsburgh 1/12/2015
Helsinn Healthcare SA Reaches Settlement Agreement Regarding Patent Dispute On ALOXI® 1/12/2015
Pluristem Therapeutics (PSTI) Granted Patent For Foundational Cell Harvesting Technology In South Africa 1/6/2015
Cellectis (ALCLS) Announces The Issuance By The USPTO Of A Patent Covering A Seminal Nuclease-Based “Gene Editing” Method 1/6/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Eurasia, Japan, And Mexico 12/30/2014
TWi Biotech Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In China 12/22/2014
BioBlast Pharma (ORPN) Receives Notice Of Patent Issuance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 12/17/2014
Suven Life Sciences Ltd Secures (5) Product Patents For Their Nces In Israel, Japan, China And New Zealand 12/12/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide 11/25/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014
Forward Pharma (FWP) Receives Issue Notification For Erosion Matrix Patent In The U.S. 11/24/2014
Ebola Vaccine Running Into Patent Cover In Canada? 11/21/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Two New U.S. Patents Relating To Topical Tetracycline Compositions 11/13/2014
Pluristem Therapeutics (PSTI) Granted Patents In Australia And New Zealand For Use Of Placental Cells In The Treatment Of Multiple Indications 11/12/2014
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS) 10/30/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
Pharmalink AB Extends Patent Protection For Nefecon® Treatment For Renal Disease 10/27/2014
ERYtech Pharma Announces Granting Of New Patent In The United States 10/21/2014
Lpath, Inc. (LPTN) Granted Key European Patent Related To iSONEP And ASONEP Programs 10/20/2014
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma (FWP), Biogen Idec (BIIB) Patent Fight 10/15/2014
Prima Biomed (PRR.AX) Announces Immutep S.A.'s IMP321 Patent Application Receives Australian Notice Of Allowance 10/14/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Improvement Patent For Neuvax® (nelipepimut-S) In Japan 10/14/2014
BTG plc (BTG.L) Reaches Settlement Regarding CroFab® Patent Litigation 10/10/2014
MediGene AG (MDGEF.PK) Receives Patent For TCR-Modified T Cell Immunotherapy In Australia 10/8/2014
Pluristem Therapeutics (PSTI) Wins Cell Therapy Patent Case In Europe; European Patent Office Confirms Validity Of Amended Claims 10/7/2014
CleveXel Pharma To License Two New Oncology Patents From SATT Sud Est 10/6/2014
U.S. Patent and Trademark Office Issues Can-Fite BioPharma (CFBI) Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/30/2014
Kymab Succeeds In Revoking Regeneron Pharmaceuticals, Inc. (REGN)’s European Patent 9/19/2014
Biostar Pharmaceuticals, Inc. (BSPM) Files A PRC Patent Application For Oleanolic Acid Injection, Its New Drug Product For Hepatitis B And Liver Cancer 9/18/2014
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014
BerGenBio AS Granted Platform Patent - Cellselect™ Platform Also Described In Peer-Reviewed Journal 9/8/2014
Can-Fite BioPharma (CFBI) Issued Japanese Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/5/2014
Suven Life Sciences Ltd Secures (3) Product Patents For Their NCEs In South Korea, China And Canada 9/3/2014
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Spain For Oral Administration Of Insulin 8/19/2014
EnGeneIC Pty Ltd Receives Patent From The USPTO For EDV™ Nanocell Technology 8/11/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 8/6/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
C4X Discovery Patent Granted In Japan 7/15/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
BioLight Announces Issuance Of U.S. Patent For The Long-Term Controlled-Release Drug-Delivery Insert Platform 7/2/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
TWi Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 In United States 6/26/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
Arjuna Natural Extracts Ltd Receives Two Japanese Patents For BCM- 95® 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014



//-->